Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Semin Liver Dis
    October 2025
  1. XU S, Calderaro J
    Combined hepatocellular-cholangiocarcinoma: a clinical and molecular review.
    Semin Liver Dis. 2025 Oct 24. doi: 10.1055/a-2730-9074.
    >> Share

    September 2025
  2. ISRAELSEN M, Trepo E, Krag A, Stender S, et al
    MetALD: Genetic Factors and Clinical Outcomes.
    Semin Liver Dis. 2025;45:269-282.
    >> Share

  3. WANG R, Ma F, Yin D, Wang H, et al
    Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2025;45:283-302.
    >> Share

  4. MRAVEC B, Szantova M
    Liver Neurobiology: Regulation of Liver Functions by the Nervous System.
    Semin Liver Dis. 2025;45:420-437.
    >> Share

  5. CAO P, Jaeschke H, Ni HM, Ding WX, et al
    The Ways to Die: Cell Death in Liver Pathophysiology.
    Semin Liver Dis. 2025;45:397-419.
    >> Share

    August 2025
  6. BALOGUN O, Nejak-Bowen K
    Animal Models of Porphyria with Hepatic Involvement.
    Semin Liver Dis. 2025 Aug 21. doi: 10.1055/a-2677-6806.
    >> Share

  7. HASSAN A, Tapper E
    Patient-centered treatment of cirrhosis.
    Semin Liver Dis. 2025 Aug 18. doi: 10.1055/a-2684-6289.
    >> Share

    June 2025
  8. BEIER JI, Luo J, Vanderpuye CM, Brizendine P, et al
    Environmental Pollutants, Occupational Exposures, and Liver Disease.
    Semin Liver Dis. 2025;45:148-166.
    >> Share

  9. GRATACOS-GINES J, Alvarado-Tapias E, Marti-Aguado D, Lopez-Pelayo H, et al
    Diagnosis and Management of Early Stages of ALD.
    Semin Liver Dis. 2025;45:195-209.
    >> Share

  10. WASHINGTON AM, Kostallari E
    Extracellular Vesicles and Micro-RNAs in Liver Disease.
    Semin Liver Dis. 2025;45:167-179.
    >> Share

  11. MARINO Z, Schilsky ML
    Wilson Disease: Novel Diagnostic and Therapeutic Approaches.
    Semin Liver Dis. 2025;45:221-235.
    >> Share

  12. BARBERA A, White TM, Arora AK, Henry L, et al
    Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2025;45:210-220.
    >> Share

  13. TORRES S, Hardesty J, Barrios M, Garcia-Ruiz C, et al
    Mitochondria and Alcohol-Associated Liver Disease: Pathogenic Role and Target for Therapy.
    Semin Liver Dis. 2025;45:180-194.
    >> Share

  14. SINGAL AK
    Preface (Introduction): Metabolic Liver Disease: A New Era in Hepatology.
    Semin Liver Dis. 2025;45:145-147.
    >> Share

    May 2025
  15. HUANG HYR, Schneider KM, Schneider C
    Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology.
    Semin Liver Dis. 2025 May 21. doi: 10.1055/a-2599-3728.
    >> Share

    April 2025
  16. JIAO H, Wang H, Li J, Yang Z, et al
    The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis.
    Semin Liver Dis. 2025 Apr 16. doi: 10.1055/a-2564-7551.
    >> Share

  17. RAMIREZ-QUESADA W, Alvarado-Tapias E, Shalaby S, Hernandez-Gea V, et al
    Recompensation in Cirrhosis: Biomarkers and Strategies.
    Semin Liver Dis. 2025 Apr 3. doi: 10.1055/a-2542-9930.
    >> Share

  18. SONG Y, Yang X, Yu C
    Understanding and Treating Hepatorenal Syndrome: Insights from Recent Research.
    Semin Liver Dis. 2025 Apr 1. doi: 10.1055/a-2570-3330.
    >> Share

    March 2025
  19. PANT K, Peixoto E, Gradilone SA
    Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases.
    Semin Liver Dis. 2025 Mar 21. doi: 10.1055/a-2563-9791.
    >> Share

  20. SEREROLS-VINAS L, Garcia-Vicien G, Ruiz-Blazquez P, Lee T, et al
    Hepatic stellate cells functional heterogeneity in liver cancer.
    Semin Liver Dis. 2025 Mar 5. doi: 10.1055/a-2551-0724.
    >> Share

  21. LIU T, Zhang F, Feng Y, Han P, et al
    Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer.
    Semin Liver Dis. 2025;45:99-113.
    >> Share

  22. HILSCHER MB, Johnson JN
    Fontan-Associated Liver Disease.
    Semin Liver Dis. 2025;45:114-128.
    >> Share

  23. POHL J, Aretakis D, Tacke F, Engelmann C, et al
    Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2025;45:52-65.
    >> Share

  24. ABI-AAD SJ, Lovell M, Khalaf RT, Sokol RJ, et al
    Pathogenesis and Management of Intestinal Failure-Associated Liver Disease.
    Semin Liver Dis. 2025;45:66-80.
    >> Share

  25. ZHANG JW, Zhang N, Lyu Y, Zhang XF, et al
    Influence of Sex in the Development of Liver Diseases.
    Semin Liver Dis. 2025;45:15-32.
    >> Share

  26. WU Q, Yang D, Liu C, Xu T, et al
    Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury.
    Semin Liver Dis. 2025;45:81-98.
    >> Share

  27. ANWAR AA, Jalan-Sakrikar N, Huebert RC
    LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology.
    Semin Liver Dis. 2025;45:1-14.
    >> Share

    January 2025
  28. PREMKUMAR M, Kajal K, Gupta P, Reddy R, et al
    Current Concepts in Fluid Resuscitation and Vasopressor Use in Cirrhosis.
    Semin Liver Dis. 2025 Jan 14. doi: 10.1055/a-2515-2783.
    >> Share

    November 2024
  29. HUDSON D, Valentin Cortez FJ, Hurtado Diaz de Leon I, Malhi G, et al
    Advancements in MELD score and its impact in Hepatology.
    Semin Liver Dis. 2024 Nov 8. doi: 10.1055/a-2464-9543.
    >> Share

  30. PRADO LG, Nagy LE
    Role of Complement in Liver Diseases.
    Semin Liver Dis. 2024;44:510-522.
    >> Share

  31. POMPILI E, Iannone G, Carrello D, Zaccherini G, et al
    Managing Multiorgan Failure in Acute on Chronic Liver Failure.
    Semin Liver Dis. 2024;44:492-509.
    >> Share

  32. SETHI N, Khokhar M, Mathur M, Batra Y, et al
    Therapeutic Potential of Nutraceuticals against Drug-Induced Liver Injury.
    Semin Liver Dis. 2024;44:430-456.
    >> Share

  33. MAHER S, Rajapakse J, El-Omar E, Zekry A, et al
    Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:457-473.
    >> Share

  34. DE JONG YP
    Mice Engrafted with Human Liver Cells.
    Semin Liver Dis. 2024;44:405-415.
    >> Share

    October 2024
  35. MEENA BL, Sarin SK
    Management of Portal vein Thrombosis in Cirrhosis.
    Semin Liver Dis. 2024 Oct 4. doi: 10.1055/s-0044-1791247.
    >> Share

    August 2024
  36. ARTEEL GE
    Extracellular matrix and hepatic wound healing before fibrosis.
    Semin Liver Dis. 2024 Aug 27. doi: 10.1055/a-2404-7973.
    >> Share

  37. BALLESTER MP, Durmazer EN, Qi T, Jalan R, et al
    The value of ammonia as a biomarker in patients with cirrhosis.
    Semin Liver Dis. 2024 Aug 2. doi: 10.1055/a-2378-8942.
    >> Share

  38. ZHANG IW, Lurje I, Lurje G, Knosalla C, et al
    Combined Organ Transplantation in Patients with Advanced Liver Disease.
    Semin Liver Dis. 2024;44:369-382.
    >> Share

  39. CHOI YJ, Kim Y, Hwang S
    Role of Neutrophils in the Development of Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:300-318.
    >> Share

  40. THAKRAL N, Desalegn H, Diaz LA, Cabrera D, et al
    A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD.
    Semin Liver Dis. 2024;44:273-286.
    >> Share

  41. CHEN C, Feng D, Wang Y, Yao T, et al
    Necrotic Liver Lesion Resolution: Another Mode of Liver Regeneration.
    Semin Liver Dis. 2024;44:333-342.
    >> Share

  42. KOTULKAR M, Paine-Cabrera D, Apte U
    Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer.
    Semin Liver Dis. 2024;44:383-393.
    >> Share

  43. QIAN S, Wang X, Chen Y, Zai Q, et al
    Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets.
    Semin Liver Dis. 2024;44:319-332.
    >> Share

    July 2024
  44. TINCOPA MA, Loomba R
    Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis.
    Semin Liver Dis. 2024 Jul 9. doi: 10.1055/s-0044-1788277.
    >> Share

    May 2024
  45. BALOGUN O, Nejak-Bowen K
    Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.
    Semin Liver Dis. 2024 May 17. doi: 10.1055/s-0044-1787076.
    >> Share

  46. MA J, Bjornsson ES, Chalasani N
    Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment.
    Semin Liver Dis. 2024 May 13. doi: 10.1055/s-0044-1787062.
    >> Share

  47. WERNER W, Kuzminskaya M, Lurje I, Tacke F, et al
    Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
    Semin Liver Dis. 2024;44:159-179.
    >> Share

  48. FISCHER AM, Lechea N, Coxson HO
    This Is What Metabolic Dysfunction-Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol.
    Semin Liver Dis. 2024;44:226-238.
    >> Share

  49. LI CC, Liu M, Lee HP, Wu W, et al
    Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives.
    Semin Liver Dis. 2024;44:133-146.
    >> Share

  50. PHAM N, Benhammou JN
    Statins in Chronic Liver Disease: Review of the Literature and Future Role.
    Semin Liver Dis. 2024;44:191-208.
    >> Share

  51. FUJIWARA N, Kimura G, Nakagawa H
    Emerging Roles of Spatial Transcriptomics in Liver Research.
    Semin Liver Dis. 2024;44:115-132.
    >> Share

    April 2024
  52. SAVIANO A, Roehlen N, Baumert TF
    Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Semin Liver Dis. 2024 Apr 22. doi: 10.1055/s-0044-1785646.
    >> Share

    March 2024
  53. KODAMA T, Takehara T
    Molecular genealogy of metabolic-associated hepatocellular carcinoma.
    Semin Liver Dis. 2024 Mar 18. doi: 10.1055/a-2289-2298.
    >> Share

    February 2024
  54. ROMERO-GOMEZ M, Arab JP, Oliveira CP, Hernandez M, et al
    Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
    Semin Liver Dis. 2024;44:69-78.
    >> Share

  55. CANIVET CM, Boursier J, Loomba R
    New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
    Semin Liver Dis. 2024;44:35-42.
    >> Share

  56. MOUZAKI M, Woo JG, Divanovic S
    Gestational and Developmental Contributors of Pediatric MASLD.
    Semin Liver Dis. 2024;44:43-53.
    >> Share

  57. TUTUSAUS A, Morales A, Garcia de Frutos P, Mari M, et al
    GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Semin Liver Dis. 2024;44:99-114.
    >> Share

  58. BESSONE F, Hillotte GL, Ahumada N, Jaureguizahar F, et al
    UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
    Semin Liver Dis. 2024;44:1-22.
    >> Share

  59. EL-KASSAS M, Awad A, Elbadry M, Arab JP, et al
    Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:54-68.
    >> Share

  60. BECH KT, Lindvig KP, Thiele M, Castera L, et al
    Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care Setting.
    Semin Liver Dis. 2024;44:23-34.
    >> Share

  61. LIU H, Sethi V, Li X, Xiao Y, et al
    Corrigendum: Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024;44:e1-e3.
    >> Share

    January 2024
  62. LIU H, Sethi V, Li X, Xiao Y, et al
    Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024 Jan 11. doi: 10.1055/a-2242-7543.
    >> Share

    November 2023
  63. BALOGUN O, Nejak-Bowen K
    The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.
    Semin Liver Dis. 2023 Nov 16. doi: 10.1055/s-0043-1776760.
    >> Share

  64. WILSON SR, Duncan AW
    The Ploidy State as a Determinant of Hepatocyte Proliferation.
    Semin Liver Dis. 2023 Nov 15. doi: 10.1055/a-2211-2144.
    >> Share

  65. HAN X, Sun Q, Xu M, Zhu G, et al
    Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
    >> Share

  66. SAEIDINEJAD M, Elshabrawi A, Sriphoosanaphan S, Andreola F, et al
    Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2023;43:429-445.
    >> Share

  67. DUTTA RK, Jun J, Du K, Diehl AM, et al
    Hedgehog Signaling: Implications in Liver Pathophysiology.
    Semin Liver Dis. 2023;43:418-428.
    >> Share

    August 2023
  68. PEKARSKA K, Parker R
    Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?
    Semin Liver Dis. 2023;43:305-310.
    >> Share

  69. RANJBARIAN T, Schnabl B
    Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2023;43:311-322.
    >> Share

  70. DESHMUKH K, Apte U
    The Role of Endoplasmic Reticulum Stress Response in Liver Regeneration.
    Semin Liver Dis. 2023;43:279-292.
    >> Share

  71. MEADOWS V, Yang Z, Basaly V, Guo GL, et al
    FXR Friend-ChIPs in the Enterohepatic System.
    Semin Liver Dis. 2023;43:267-278.
    >> Share

  72. COOPER SA, Kostallari E, Shah VH
    Angiocrine Signaling in Sinusoidal Health and Disease.
    Semin Liver Dis. 2023;43:245-257.
    >> Share

  73. RUIZ M, Lacaille F, Schrader C, Pons M, et al
    Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Semin Liver Dis. 2023;43:258-266.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016